Topics

Sarepta Therapeutics CEO playing nice with FDA over rejection of Duchenne drug https://www.statnews.com/2019/11/07/sarepta-therapeutics-ceo-fda-duchenne-drug/ … $SRPT

17:45 EST 7 Nov 2019 | STAT

Sarepta Therapeutics CEO playing nice with FDA over rejection of Duchenne drug https://www.statnews.com/2019/11/07/sarepta-therapeutics-ceo-fda-duchenne-drug/ …

Original Article: Sarepta Therapeutics CEO playing nice with FDA over rejection of Duchenne drug https://www.statnews.com/2019/11/07/sarepta-therapeutics-ceo-fda-duchenne-drug/ … $SRPT

NEXT ARTICLE

More From BioPortfolio on "Sarepta Therapeutics CEO playing nice with FDA over rejection of Duchenne drug https://www.statnews.com/2019/11/07/sarepta-therapeutics-ceo-fda-duchenne-drug/ … $SRPT"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...